The relationship between epicardial adipose tissue volume (EATV) and plaque vulnerability in non-culprit coronary lesions is not clearly understood.
picardial adipose tissue (EAT) has specific characteristics and is the source of several inflammatory mediators in patients with cardiac disease. [1] [2] [3] [4] The blood supply of paracardial adipose tissue is derived from non-coronary vessels, such as the pericardiacophrenic branches of the internal mammary artery, while EAT is supplied by the coronary arteries. 5) We previously reported an association between increased epicardial adipose tissue volume (EATV) and the composition of culprit coronary plaques. 6) Vulnerable plaque is related to coronary events. 7, 8) On the contrary, non-culprit lesions were reportedly associated with future cardiovascular events in patients with acute coronary syndrome. 9) These reports suggest that the assessment of the total plaque volume and composition may be useful for predicting future cardiovascular events. The iMAP system assesses plaque composition by spectral analysis of radiofrequency data obtained with intravascular ultrasound (IVUS). Accordingly, we used the iMAP imaging system to investigate the relationship between EATV and subtypes of plaque volumes in the total coronary artery tree of patients with stable angina in the present study.
Methods
We prospectively enrolled consecutive patients undergoing elective percutaneous coronary intervention (PCI) at Showa University Northern Yokohama Hospital (Kanagawa, Japan) from June 2012 to February 2013 ( Figure  1 ). This study was registered with the University Hospital Medical Information Network Clinical Trials Registry (identifier: UMIN 000010766).
Inclusion criteria were patients of either sex who were scheduled to undergo PCI, aged over 20 years at the Yamashita, ET AL time of giving informed consent, able to provide written informed consent, and had undergone a multi-slice computed tomography (CT) study within 3 months before index PCI. Patients with any of the following were excluded from this study: 1) a history of PCI or coronary artery bypass grafting, 2) chronic kidney disease (serum creatinine > 1.5 mg/dL), and 3) severe coronary calcification (Agatston score > 400). Four patients were excluded because of inadequate image quality. As a result, this study assessed 158 coronary vessels in 54 consecutive patients. Smoking status, medical history, and current cardiovascular medications (for hypertension, dyslipidemia, and diabetes) were investigated by asking the patients to complete a questionnaire. Height (meters) and weight (kilograms) were measured before coronary angiography to calculate the body mass index. Systolic and diastolic blood pressures were measured while the patient was in the supine position before CT was carried out.
PCI was performed according to standard methods via the radial or femoral approach using a 6 F or larger guide catheter. Treatment using oral aspirin (100 mg daily) was initiated before the procedure. After sheath insertion, bolus doses of unfractionated heparin (150 unit/ kg) were administered during the procedure to maintain the activated clotting time in the 250-300 second range. The activated clotting time was measured both before PCI and every 60 minutes after the start of the procedure. PCI was only performed if the patient had no contraindications, such as aspirin or ticlopidine intolerance or scheduled non-cardiac surgery. After PCI, dual antiplatelet therapy based on clopidogrel (75 mg daily after a loading dose of 300 mg) was continued for at least 8 months in all patients.
The minimum luminal diameter, reference diameter, and pre-and post-procedural percent diameter stenosis of each lesion were determined using an automated edge detection system (CASSII; PieMedical, Maastricht, The Netherlands). Images were analyzed by a radiologist who was not involved in the study to avoid bias. The contrastfilled catheter tip was used as the calibration standard. All measurements were performed on cine angiograms recorded after the intracoronary administration of nitroglycerin. QCA measurements were obtained on both an instent basis (confined to the stented region) and in-segment basis (including the vessel 5 mm proximal and distal to the stent). The reference diameter was defined as the average of the proximal and distal reference diameters of the target vessel before PCI.
IVUS was performed before PCI in all patients. Briefly, after the intracoronary administration of nitroglycerin (125-250 μg), a 3.6 Fr 40 MHz IVUS catheter (Opti-Cross; Boston Scientific Corporation, Minneapolis, MN) was introduced into the distal coronary artery after 0.2 mg of intracoronary nitroglycerin. Then the catheter was withdrawn using an automatic pullback system at a rate of 0.5 mm/s until coronary ostium was observed. Quantitative volumetric analysis of the IVUS data was carried out according to the American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement, and Reporting of IVUS. 10) The vessel wall and lumen were manually traced at 0.5-mm intervals. The detection of the luminal contour and the media-adventitia interface was performed by an independent experienced IVUS analyst (M.Y.) using dedicated software (QIvus, Medis, Leiden, The Netherlands).
Then, the luminal volume, vessel volume, and plaque volume (vessel volume-luminal volume) were computed within all coronary arteries using Simpson's method. The minimum luminal cross-sectional area (MLA) was defined as the smallest luminal cross-sectional area inside the le-EATV AND CORONARY ATHEROSCLEROSIS sion. The reference vessel cross-sectional area was defined as the mean value of the proximal and distal crosssectional areas of the reference vessel. Percent stenosis was calculated as (MLA reference vessel crosssectional area) × 100, while the remodeling index was calculated as cross-sectional area at the MLA site reference vessel cross-sectional area. Briefly, the iMAP system (Boston Scientific, Natick, MA, USA) was used for spectral analysis of IVUS radiofrequency data. The vessel borders and lumen were identified by automatic edge detection, with manual correction when necessary. Then, the iMAP system used a previously reported algorithm to automatically classify plaque into 4 major components, which were fibrous tissue, lipid tissue, necrotic tissue, and calcified tissue ( Figure 2 ). 11) Plaque was automatically deleted if it was unsuitable for analysis because of acoustic shadowing behind calcification or wire artifacts.
A dual-source CT system (Somatom Definition; Siemens Medical Solutions, Forchheim, Germany) was used with the following settings: detector collimation of 64 × 0.625 mm, table feed of 19.7 mm/second, helical pitch (beam pitch) of 0.17, rotation time of 280 ms, tube cur-rent of 370 mA second, and voltage of 120 kVp. Scanning time varied from 6 to 8 seconds. Raw data were reconstructed at 75% of the RR wave or the specific optimal phase. A bolus dose of contrast medium (iohexol containing 350 mg of iodine/mL; Omnipaque, Daiichi-Sankyo Pharmaceutical, Tokyo, Japan) was injected within 9 s at a dose of 0.6 mL/kg. In all patients, a β-blocker (bisoprolol fumarate: 2.5 mg) was orally administrated 1 hour before CT scanning and nitroglycerin (0.3 mg) was administered just before scanning. Reconstructed CT scans were transferred to a workstation for post-processing (Ziostation; Amin, Tokyo, Japan). Coronary artery calcification was quantified by determining the Agatston score. 12) EAT was defined as any adipose tissue located within the pericardial sac and was identified on contrastenhanced CT scans as a hypodense rim surrounding the myocardium and limited by the pericardium. Axial slices of the heart (0.75-mm thickness) were obtained from the level of the right pulmonary artery to the diaphragm, and a predefined image display setting was used [window width of 80 HU and window center of −110 HU] to identify the pixels corresponding to adipose tissue ( Figure  Yamashita A, B) . The epicardial adipose tissue area (orange) was determined by tracing a single region of interest on an axial image. Fat voxels were identified by using a threshold attenuation range of -190 to -30 HU. EATV (cm 3 ) was automatically calculated as the sum of the fat areas at least 0.625 mm thick for the whole heart. EATV indicates epicardial adipose tissue volume.
3). 13) Then, readers who were blinded to the clinical data performed trimming along the pericardial sac on axial, coronal, and sagittal slices as well as on volume-rendered images.
Data were analyzed with JMP software 13 (SAS Institute, Cary, NC, USA) using analysis of variance. Categorical variables were expressed as frequencies and were compared with Fisher's exact test or Pearson's chi-square test, while continuous variables were presented as the mean ± standard deviation if normal distribution. Comparison of normally distributed variables between groups was performed using an independent-sample and paired ttest, as appropriate.
Relations between the composition of coronary plaque and EATV were initially investigated using univariate linear regression analysis, followed by multivariate analysis based on the univariate results. All the independent variables with a univariate P value less than 0.25 were included in the model. A multivariate linear model was used. In all analyses, a probability (P) value < 0.05 was considered to indicate statistical significance.
Written informed consent was obtained from all subjects, and the ethics committee of our institution approved the protocol of this study.
Results
In all patients, the mean EATV was 75.4 cm 3 (range: 30.2 to 131.8 cm 3 ). Using this mean value, the patients were divided into group L (EATV < 75.4 cm 3 , n = 27, 79 coronary arteries) and group H (EATV !75.4 cm 3 , n = 27, 79 coronary arteries).
The assessment of baseline clinical characteristics revealed no significant differences between the 2 groups in terms of age, gender, abdominal circumference, hypertension, diabetes, and dyslipidemia (Table I) . The body mass index and serum fasting blood glucose level were higher in group H but the differences were not significant. Table  II showed angiographic, CT, and IVUS data. There was no significant difference angiographically. CT angiography also showed no differences in the distribution of culprit vessels and the number of diseased vessels. The total coronary artery length analyzed by IVUS also did not differ between the 2 groups. However, total luminal volume, total vessel volume, and total plaque volume were significantly larger in group H than in group L. Moreover, fibrotic plaque volume and lipidic plaque volume were significantly larger in group H.
When we assessed relations between EATV and each plaque component in the total coronary artery tree, there was a significant negative correlation between EATV and EATV AND CORONARY ATHEROSCLEROSIS fibrous plaque tissue (r = −0.31, P = 0.02), as well as a significant positive correlation between EATV and necrotic plaque tissue (r = 0.37, P = 0.007) ( Figure 4 ). However, total lipidic plaque tissue and total calcified plaque tissue showed no significant correlation with EATV. Table III displays the relationship of EATV with plaque components in each coronary artery. There was a significant positive correlation between EATV and necrotic plaque tissue in the left anterior descending artery (LAD) and the right coronary artery (RCA). However, there was no significant correlation between EATV and any plaque component in the left circumflex artery (LCx).
We also conducted multivariate analysis to investigate the variables related to total plaque volume, identifying low-density lipoprotein cholesterol (β = 0.38, P = 0.03) and EATV (β = 0.31, P = 0.04) as predictors of the total coronary plaque burden.
Discussion
The main findings of this study were as follows. First, EATV was not only associated with the volume and composition of the culprit coronary plaque, but also with the volume and composition of total coronary plaque. Second, there was a positive correlation between EATV and the total necrotic plaque component, while there was a negative correlation between EATV and the total fibrotic plaque component. Third, the association between EATV and plaque components in the LAD or RCA was similar to that between EATV and plaque in the total coronary tree, but LCx plaque was not associated with EATV.
There have already been some reports about the relationship between EAT and coronary plaque burden based on coronary CT data, 14, 15) but there have been none about the association between EAT and coronary plaque burden based on IVUS. EAT is not only a site of energy storage as free fatty acids (FFA), 16) but also acts as a paracrine organ that releases both FFA and vasoactive cytokines directly into the coronary vessels. The results of several previous studies have suggested that EAT may contribute to the pathogenesis of coronary artery disease. 2, [17] [18] [19] [20] [21] [22] Epicardial fat thickness is an independent predictor of coronary atherosclerosis. Patients with a high EATV have an elevated risk of coronary events and may need both lipid-lowering therapy and strict dietary manage-ment. 23) It is well known that EATV shows an association with the severity of coronary artery disease and with potentially unstable atherosclerotic plaque rather than stable plaque (fibrous plaque). 17, 18, [20] [21] [22] 24, 25) Betteencourt, et al. 14) and Gitsioudis, et al. 15) previously found a positive correlation between EAT and the coronary plaque burden by using coronary CT. In the present study, we did not identify an association of calcified plaque with EAT. IVUS has a higher spatial resolution than coronary CT, but we excluded patients with a high Agatson score (>400) because it was impossible to measure their plaque volume and components due to artifacts. However, CT can be affected by blooming and shooting artifacts.
Gaborit, et al. 26) reported that peri-coronary adipose tissue is a stronger predictor of plaque vulnerability than EAT. Peri-atrial EAT has been reported to differ from peri-ventricular EAT and peri-coronary EAT with regard to the expression of genes involved in oxidative phosphorylation, muscle contraction, and calcium signaling. In the present study, we did not compare the association of periatrial EAT and peri-ventricular EAT to coronary plaque components. However, the RCA and LCx are located in the atrioventricular groove, so EAT around these vessels may be different from that around the LAD. A prospective study would be necessary to confirm the relationship between different types of EAT and progression of each coronary plaque component.
There were some limitations of this study. First, the sample size was relatively small because the subjects were required to undergo coronary IVUS. Second, we only studied patients with known coronary artery disease and we were unable to assess the relationship between EAT and coronary plaque in a healthy population without cardiovascular disease, suggesting the possibility of selection bias. Third, we analyzed 3 main coronary arteries, but did not investigate their branches. However, it was impossible to investigate all of the coronary branches because of time limitations and because many vessels are too small for the IVUS probe. Finally, further research will be needed to investigate the changes of stented lesions and non-culprit plaques in the future.
Conclusions
We demonstrated that an increase in EATV was associated with a larger coronary plaque burden, especially in the LAD and RCA.
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